Search Pay Bill Contact Us Company Innovation Publications Investors Publications We conduct and publish research to advance our innovation pipeline and propel healthcare forward. Featured Publication Performance of a novel multi-biomarker rule-out test for preeclampsia A prospective verification study demonstrates that the Preecludia™ test has high sensitivity and high negative predictive value. May 19, 2021 Home Publications Browsing Options Sort by newest Publication Categories Carrier Testing Concurrent DNA may be the right way Guidelines for identifying hemoglobinopathy carriers recommend genotyping only for certain patients. But these results show that concurrent testing may be the way to go. January 06, 2020#Carrier Testing Beta-hemoglobinopathies: lessons in diversity Sickle cell anemia (Hb S) is a classic study in carrier status and recessive inheritance, but the beta-hemoglobinopathies are far more complex than they seem. This study highlights the diversity within this group of disorders, and within the ethnicities at risk. October 26, 2018#Carrier Testing The curious variability in risks associated with alpha-thalassemia Not all carriers of alpha-thalassemia have the same disease transmission outcomes. Read more about how the ethnicity with the highest carrier frequency is not the ethnicity with the highest risk of having an affected child. October 09, 2018#Carrier Testing Are fragile X premutations more common in women with infertility? Not all carriers of alpha-thalassemia have the same disease transmission outcomes. Read more about how the ethnicity with the highest carrier frequency is not the ethnicity with the highest risk of having an affected child. September 07, 2018#Carrier Testing People are carriers more often than you think Expanding carrier testing means finding more at-risk patients. This research tells you just how many more you can find. July 06, 2018#Carrier Testing The true impact of fragile X syndrome Hereditary cancer risk assessment is standard of care in obstetrics and gynecology (ob/gyn) practice. Chatbots can help assess who is at risk. July 02, 2018#Carrier Testing Previous 1 Next Search the Site Connect With Us Company About Progenity Careers at Progenity Compliance Leadership Privacy & Terms of Use Innovation Preecludia™ Gastrointestinal Health Oral Biotherapeutics Publications Gastrointestinal Health Preeclampsia Investors News & Events Stock Information Corporate Governance Financials & Filings IR Resources © Progenity, Inc. All rights reserved. Progenity® is a registered service mark of Progenity, Inc. Preecludia™ is a trademark of Progenity, Inc. All other trademarks are the property of their respective owners. Please review our updated Website Privacy Policy, which describes our practices related to the collection, use, and disclosure of your personal information.Cookie Policy Cookies Settings Accept All Cookies